OBJECTIVES: We tested the hypothesis that higher rates of previous hard drug-related arrests predict lower rates of injection drug use. METHODS: We analyzed drug-related arrest data from the Federal Bureau of Investigation's Uniform Crime Reporting Program for 93 large US metropolitan statistical areas in 1992 to 2002 to predict previously published annual estimates of the number of injection drug users (IDUs) per 10,000 population. RESULTS: In linear mixed-effects regression, hard drug-related arrest rates were positively associated (parameter = +1.59; SE = 0.57) with the population rate of IDUs in 1992 and were not associated with change in the IDU rate over time (parameter = -0.15; SE = 0.39). CONCLUSIONS: Deterrence-based approaches to reducing drug use seem not to reduce IDU prevalence. Alternative approaches such as harm reduction, which prevents HIV transmission and increases referrals to treatment, may be a better foundation for policy.
OBJECTIVES: We tested the hypothesis that higher rates of previous hard drug-related arrests predict lower rates of injection drug use. METHODS: We analyzed drug-related arrest data from the Federal Bureau of Investigation's Uniform Crime Reporting Program for 93 large US metropolitan statistical areas in 1992 to 2002 to predict previously published annual estimates of the number of injection drug users (IDUs) per 10,000 population. RESULTS: In linear mixed-effects regression, hard drug-related arrest rates were positively associated (parameter = +1.59; SE = 0.57) with the population rate of IDUs in 1992 and were not associated with change in the IDU rate over time (parameter = -0.15; SE = 0.39). CONCLUSIONS: Deterrence-based approaches to reducing drug use seem not to reduce IDU prevalence. Alternative approaches such as harm reduction, which prevents HIV transmission and increases referrals to treatment, may be a better foundation for policy.
Authors: Scott Burris; Kim M Blankenship; Martin Donoghoe; Susan Sherman; Jon S Vernick; Patricia Case; Zita Lazzarini; Stephen Koester Journal: Milbank Q Date: 2004 Impact factor: 4.911
Authors: Samuel R Friedman; Hannah Lf Cooper; Barbara Tempalski; Maria Keem; Risa Friedman; Peter L Flom; Don C Des Jarlais Journal: AIDS Date: 2006-01-02 Impact factor: 4.177
Authors: Hannah L F Cooper; Brooke West; Sabriya Linton; Josalin Hunter-Jones; Maria Zlotorzynska; Ron Stall; Mary E Wolfe; Leslie Williams; H Irene Hall; Charles Cleland; Barbara Tempalski; Samuel R Friedman Journal: Am J Public Health Date: 2015-12-21 Impact factor: 9.308
Authors: Sudip Chatterjee; Barbara Tempalski; Enrique R Pouget; Hannah L F Cooper; Charles M Cleland; Samuel R Friedman Journal: AIDS Behav Date: 2011-10
Authors: Traci C Green; Nickolas Zaller; Wilson R Palacios; Sarah E Bowman; Madeline Ray; Robert Heimer; Patricia Case Journal: Drug Alcohol Depend Date: 2013-09-02 Impact factor: 4.492
Authors: Peter Meylakhs; Samuel R Friedman; Anastasia Meylakhs; Pedro Mateu-Gelabert; Danielle C Ompad; Alisa Alieva; Alexandra Dmitrieva Journal: AIDS Behav Date: 2019-12
Authors: Kora DeBeck; Tessa Cheng; Julio S Montaner; Chris Beyrer; Richard Elliott; Susan Sherman; Evan Wood; Stefan Baral Journal: Lancet HIV Date: 2017-05-14 Impact factor: 12.767
Authors: Samuel R Friedman; Brooke S West; Barbara Tempalski; Cory M Morton; Charles M Cleland; Don C Des Jarlais; H Irene Hall; Hannah L F Cooper Journal: Ann Epidemiol Date: 2014-01-24 Impact factor: 3.797
Authors: Samuel R Friedman; Barbara Tempalski; Joanne E Brady; Brooke S West; Enrique R Pouget; Leslie D Williams; Don C Des Jarlais; Hannah L F Cooper Journal: Int J Drug Policy Date: 2016-03-11